Lapatinib Completed Phase 2 Trials for Gliomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00350727Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma